Age-related vascular pathology in transgenic mice expressing presenilin 1-associated familial Alzheimer's disease mutations

American Journal of Pathology

Volumn 176, Issue 1, 2010, Pages 353-368

  Gama Sosa, Miguel A ^a,b   De Gasperi, Rita ^a,b   Rocher, Anne B ^b,c   Wang, Athena Ching Jung ^b   Janssen, William G M ^b   Flores, Tony ^b   Perez, Gissel M ^a,b   Schmeidler, James ^b   Dickstein, Dara L ^b   Hof, Patrick R ^b   Elder, Gregory A ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; PRESENILIN 1;

ALZHEIMER DISEASE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; BLEEDING; BRAIN ATROPHY; BRAIN BLOOD VESSEL; CONTROLLED STUDY; ENDOTHELIUM CELL; FAMILIAL DISEASE; GENE EXPRESSION; GENE MUTATION; GLIA CELL; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MICROANGIOPATHY; MICROVASCULATURE; MOUSE; MOUSE MUTANT; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; TRANSGENE; TRANSGENIC MOUSE; VASCULAR DISEASE;

EID: 73949119034     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.090482     Document Type: Article

References (56)

1. Ertekin-Taner N: Genetics of Alzheimer's disease: a centennial review. Neurol Clin 2007, 25:611-667
2. Lleo A, Berezovska O, Growdon JH, Hyman BT: Clinical, pathological, and biochemical spectrum of Alzheimer disease associated with PS-1 mutations. Am J Geriatr Psychiatry 2004, 12:146-156
3. Kumar-Singh S: Cerebral amyloid angiopathy: pathogenetic mechanisms and link to dense amyloid plaques. Genes Brain Behav 2008, 7(Suppl)1:67-82
4. Revesz T, Ghiso J, Lashley T, Plant G, Rostagno A, Frangione B, Holton JL: Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view. J Neuropathol Exp Neurol 2003, 62:885-898
5. Bailey TL, Rivara CB, Rocher AB, Hof PR: The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease. Neurol Res 2004, 26:573-578
6. Buée L, Hof PR, Bouras C, Delacourte A, Perl DP, Morrison JH, Fillit HM: Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders. Acta Neuropathol (Berl) 1994, 87:469-480
7. Kumar-Singh S, Pirici D, McGowan E, Serneels S, Ceuterick C, Hardy J, Duff K, Dickson D, Van Broeckhoven C: Dense-core plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls. Am J Pathol 2005, 167:527-543
8. Van Dorpe J, Smeijers L, Dewachter I, Nuyens D, Spittaels K, Van Den Haute C, Mercken M, Moechars D, Laenen I, Kuiperi C, Bruynseels K, Tesseur I, Loos R, Vanderstichele H, Checler F, Sciot R, Van Leuven F: Prominent cerebral amyloid angiopathy in transgenic mice over-expressing the London mutant of human APP in neurons. Am J Pathol 2000, 157:1283-1298
9. Calhoun ME, Burgermeister P, Phinney AL, Stalder M, Tolnay M, Wiederhold KH, Abramowski D, Sturchler-Pierrat C, Sommer B, Staufenbiel M, Jucker M: Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc Natl Acad Sci USA: 1999, 96:14088-14093
10. Herzig MC, Winkler DT, Burgermeister P, Pfeifer M, Kohler E, Schmidt SD, Danner S, Abramowski D, Sturchler-Pierrat C, Burki K, van Duinen SG, Maat-Schieman ML, Staufenbiel M, Mathews PM, Jucker M: Aβ is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. Nat Neurosci 2004, 7:954-960
11. Tong XK, Nicolakakis N, Kocharyan A, Hamel E: Vascular remodeling versus amyloid β-induced oxidative stress in the cerebrovascular dysfunctions associated with Alzheimer's disease. J Neurosci 2005, 25:11165-11174
12. Lopez-Lopez C, Dietrich MO, Metzger F, Loetscher H, Torres-Aleman I: Disturbed cross-talk between insulin-like growth factor I and AMP-activated protein kinase as a possible cause of vascular dysfunction in the amyloid precursor protein/presenilin 2 mouse model of Alzheimer's disease. J Neurosci 2007, 27:824-831
13. Wen PH, Hof PR, Chen X, Gluck K, Austin G, Younkin SG, Younkin LH, DeGasperi R, Gama Sosa MA, Robakis NK, Haroutunian V, Elder GA: The presenilin-1 familial Alzheimer disease mutant P117L impairs neurogenesis in the hippocampus of adult mice. Exp Neurol 2004, 188:224-237
14. Wen PH, Shao X, Shao Z, Hof PR, Wisniewski T, Kelley K, Friedrich VL Jr, Ho L, Pasinetti GM, Shioi J, Robakis NK, Elder GA: Overexpression of wild type but not an FAD mutant Presenilin-1 promotes neurogenesis in the hippocampus of adult mice. Neurobiol Dis 2002, 10:8-19
15. Rogaev EI, Sherrington R, Wu C, Levesque G, Liang Y, Rogaeva EA, Ikeda M, Holman K, Lin C, Lukiw WJ, de Jong PJ, Fraser PE, Rommens JM, St George-Hyslop P: Analysis of the 5′ sequence, genomic structure, and alternative splicing of the presenilin-1 gene (PSEN1) associated with early onset Alzheimer disease. Genomics 1997, 40:415-424
16. Gama Sosa MA, DeGasperi R, Gonzalez EA, Kelley K, Lazzarini R, Elder GA: BAC and PAC DNA for the generation of transgenic animals. Biotechniques 2002, 33:51-53
17. Ali Imam AM, Patrinos GP, de Krom M, Bottardi S, Janssens RJ, Katsantoni E, Wai AWK, Sherrat DJ, Grosveld FG: Modification of human β-globin locus PAC clones by homologous recombination in Escherichia coli. Nucleic Acids Res 2000, 28:e65
18. Shen J, Bronson RT, Chen DF, Xia W, Selkoe DJ, Tonegawa S: Skeletal and CNS defects in Presenilin-1-deficient mice. Cell 1997, 89:629-639
19. Schmidt ML, Robinson KA, Lee VM, Trojanowski JQ: Chemical and immunological heterogeneity of fibrillar amyloid in plaques of Alzheimer's disease and Down's syndrome brains revealed by confocal microscopy. Am J Pathol 1995, 147:503-515
20. Franciosi S, De Gasperi R, Dickstein DL, English DF, Rocher AB, Janssen WG, Christoffel D, Sosa MA, Hof PR, Buxbaum JD, Elder GA: Pepsin pretreatment allows collagen IV immunostaining of blood vessels in adult mouse brain. J Neurosci Methods 2007, 163:76-82
21. Calhoun ME, Mouton PR: Length measurement: new developments in neurostereology and 3D imagery. J Chem Neuroanat 2001, 21:257-265
22. Kreczmanski P, Schmidt-Kastner R, Heinsen H, Steinbusch HW, Hof PR, Schmitz C: Stereological studies of capillary length density in the frontal cortex of schizophrenics. Acta Neuropathol (Berl) 2005, 109:510-518
23. Mouton PR, Gokhale AM, Ward NL, West MJ: Stereological length estimation using spherical probes. J Microsc 2002, 206:54-64
24. Schmitz C, Hof PR: Design-based stereology in neuroscience. Neuroscience 2005, 130:813-831
25. Janssen WG, Vissavajjhala P, Andrews G, Moran T, Hof PR, Morrison JH: Cellular and synaptic distribution of NR2A and NR2B in macaque monkey and rat hippocampus as visualized with subunit-specific monoclonal antibodies. Exp Neurol 2005, 191(Suppl 1):S28-S44
26. Chaudhry FA, Lehre KP, van Lookeren Campagne M, Ottersen OP, Danbolt NC, Storm-Mathisen J: Glutamate transporters in glial plasma membranes: highly differentiated localizations revealed by quantitative ultrastructural immunocytochemistry. Neuron 1995, 15:711-720
27. Hjelle OP, Chaudhry FA, Ottersen OP: Antisera to glutathione: characterization and immunocytochemical application to the rat cerebellum. Eur J Neurosci 1994, 6:793-804
28. van Lookeren Campagne M, Oestreicher AB, van der Krift TP, Gispen WH, Verkleij AJ: Freeze-substitution and Lowicryl HM20 embedding of fixed rat brain: suitability for immunogold ultrastructural localization of neural antigens. J Histochem Cytochem 1991, 39:1267-1279
29. Elder GA, Tezapsidis N, Carter J, Shioi J, Bouras C, Li H-C, Johnston JM, Efthimiopoulos S, Friedrich VL, Robakis NK: Identification and neuron specific expression of the S182/presenilin I protein in human and rodent brains. J Neurosci Res 1996, 45:308-320
30. Qian S, Jiang P, Guan XM, Singh G, Trumbauer ME, Yu H, Chen HY, Van de Ploeg LH, Zheng H: Mutant human presenilin 1 protects presenilin 1 null mouse against embryonic lethality and elevates Aβ1-42/43 expression. Neuron 1998, 20:611-617
31. Davis JA, Naruse S, Chen H, Eckman C, Younkin S, Price DL, Borchelt DR, Sisodia SS, Wong PC: An Alzheimer's disease-linked PS1 variant rescues the developmental abnormalities of PS1-deficient embryos. Neuron 1998, 20:603-609
32. Duff K, Eckman C, Zehr C, Yu X, Prada CM, Perez-tur J, Hutton M, Buee L, Harigaya Y, Yager D, Morgan D, Gordon MN, Holcomb L, Refolo L, Zenk B, Hardy J, Younkin S: Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1. Nature 1996, 383:710-713
33. Chishti MA, Yang DS, Janus C, Phinney AL, Horne P, Pearson J, Strome R, Zuker N, Loukides J, French J, Turner S, Lozza G, Grilli M, Kunicki S, Morissette C, Paquette J, Gervais F, Bergeron C, Fraser PE, Carlson GA, George-Hyslop PS, Westaway D: Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem 2001, 276:21562-21570
34. Mandybur TI: Cerebral amyloid angiopathy: the vascular pathology and complications. J Neuropathol Exp Neurol 1986, 45:79-90
35. Vinters HV: Cerebral amyloid angiopathy: a critical review. Stroke 1987, 18:311-324
36. Zarow C, Barron E, Chui HC, Perlmutter LS: Vascular basement membrane pathology and Alzheimer's disease. Ann NY Acad Sci 1997, 826:147-160
37. Jucker M, Bialobok P, Hagg T, Ingram DK: Laminin immunohisto-chemistry in brain is dependent on method of tissue fixation. Brain Res 1992, 586:166-170
38. Mori S, Sternberger NH, Herman MM, Sternberger LA: Variability of laminin immunoreactivity in human autopsy brain. Histochemistry 1992, 97:237-241
39. Busciglio J, Hartmann H, Lorenzo A, Wong C, Baumann K, Sommer B, Staufenbiel M, Yankner BA: Neuronal localization of presenilin-1 and association with amyloid plaques and neurofibrillary tangles in Alzheimer's disease. J Neurosci 1997, 17:5101-5107
40. Cribbs DH, Chen LS, Bende SM, LaFerla FM: Widespread neuronal expression of the presenilin-1 early-onset Alzheimer's disease gene in the murine brain. Am J Pathol 1996, 148:1797-1806
41. Lee MK, Slunt HH, Martin LJ, Thinakaran G, Kim G, Gandy SE, Seeger M, Koo E, Price DL, Sisodia SS: Expression of presenilin 1 and 2 (PS1 and PS2) in human and murine tissues. J Neurosci 1996, 16:7513-7525
42. Walsh DM, Selkoe DJ: Aβ oligomers-a decade of discovery. J Neurochem 2007, 101:1172-1184
43. Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, Bird TD, Hardy J, Hutton M, Kukull W, Larson E, Levy-Lahad E, Viitanen M, Peskind E, Poorkaj P, Schellenberg G, Tanzi R, Wasco W, Lannfelt L, Selkoe D, Younkin S: Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med 1996, 2:864-870
44. Szabo A, Kalman M: Disappearance of the post-lesional laminin immunopositivity of brain vessels is parallel with the formation of gliovascular junctions and common basal lamina: a double-labelling immunohistochemical study. Neuropathol Appl Neurobiol 2004, 30:169-177
45. Caley DW, Maxwell DS: Development of the blood vessels and extracellular spaces during postnatal maturation of rat cerebral cortex. J Comp Neurol 1970, 138:31-47
46. Chiappelli M, Borroni B, Archetti S, Calabrese E, Corsi MM, Franceschi M, Padovani A, Licastro F: VEGF gene and phenotype relation with Alzheimer's disease and mild cognitive impairment. Rejuvenation Res 2006, 9:485-493
47. Thirumangalakudi L, Samany PG, Owoso A, Wiskar B, Grammas P: Angiogenic proteins are expressed by brain blood vessels in Alzheimer's disease. J Alzheimers Dis 2006, 10:111-118
48. Tarkowski E, Issa R, Sjogren M, Wallin A, Blennow K, Tarkowski A, Kumar P: Increased intrathecal levels of the angiogenic factors VEGF and TGF-β in Alzheimer's disease and vascular dementia. Neurobiol Aging 2002, 23:237-243
49. Grammas P, Ovase R: Cerebrovascular transforming growth factor-β contributes to inflammation in the Alzheimer's disease brain. Am J Pathol 2002, 160:1583-1587
50. Desai BS, Schneider JA, Li JL, Carvey PM, Hendey B: Evidence of angiogenic vessels in Alzheimer's disease. J Neural Transm 2009, 116:587-597
51. Wyss-Coray T, Lin C, Sanan DA, Mucke L, Masliah E: Chronic overproduction of transforming growth factor-β1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice. Am J Pathol 2000, 156:139-150
52. Weller RO, Massey A, Newman TA, Hutchings M, Kuo YM, Roher AE: Cerebral amyloid angiopathy: amyloid β accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. Am J Pathol 1998, 153:725-733
53. Zlokovic BV: The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008, 57:178-201
54. Cribbs DH, Chen LS, Cotman CW, LaFerla FM: Injury induces presenilin-1 gene expression in mouse brain. Neuroreport 1996, 7:1773-1776
55. Huynh DP, Vinters HV, Ho DH, Ho VV, Pulst SM: Neuronal expression and intracellular localization of presenilins in normal and Alzheimer disease brains. J Neuropathol Exp Neurol 1997, 56:1009-1017
56. Wen PH, De Gasperi R, Sosa MA, Rocher AB, Friedrich VL Jr, Hof PR, Elder GA: Selective expression of presenilin 1 in neural progenitor cells rescues the cerebral hemorrhages and cortical lamination defects in presenilin 1-null mutant mice. Development 2005, 132:3873-3883